Polaris AI Pharma Corp. (KOSDAQ:041910)
6,840.00
+190.00 (2.86%)
At close: Jan 23, 2026
Polaris AI Pharma Revenue
Polaris AI Pharma had revenue of 14.14B KRW in the quarter ending September 30, 2022, with 0.05% growth. This brings the company's revenue in the last twelve months to 63.94B, up 8.69% year-over-year. In the year 2021, Polaris AI Pharma had annual revenue of 60.40B, down -1.51%.
Revenue (ttm)
63.94B
Revenue Growth
+8.69%
P/S Ratio
1.42
Revenue / Employee
399.60M
Employees
160
Market Cap
90.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 60.40B | -923.01M | -1.51% |
| Dec 31, 2020 | 61.32B | 14.83B | 31.91% |
| Dec 31, 2019 | 46.49B | 6.15B | 15.26% |
| Dec 31, 2018 | 40.34B | 2.12B | 5.55% |
| Dec 31, 2017 | 38.21B | -5.18B | -11.94% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| H.PIO | 257.56B |
| Daehan Nupharm | 201.59B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| Sinil Pharmaceutical | 80.97B |
| Sam-A Pharm. | 76.66B |